Abstract
Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.)
Original language | English |
---|---|
Article number | 101841 |
Journal | JACC: Case Reports |
Volume | 14 |
DOIs | |
Publication status | Published - 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Authors
Keywords
- percutaneous
- transcatheter valve therapy
- tricuspid regurgitation
- valve replacement